These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 2819618)
1. Choices in treating carcinoma of the esophagus. Skinner DB Can J Surg; 1989 Nov; 32(6):420-3. PubMed ID: 2819618 [TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus]. Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287 [TBL] [Abstract][Full Text] [Related]
3. A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma. Yamashita H; Okuma K; Seto Y; Mori K; Kobayashi S; Wakui R; Ohtomo K; Nakagawa K J Surg Oncol; 2009 Nov; 100(6):435-41. PubMed ID: 19653240 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911 [TBL] [Abstract][Full Text] [Related]
5. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Mariette C; Piessen G; Briez N; Triboulet JP Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546 [TBL] [Abstract][Full Text] [Related]
6. [Palliative treatment in patients with oesophagus carcinoma]. Siersema PD; Verschuur EM; Homs MY; van der Gaast A; Eijkenboom WM; Kuipers EJ Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2775-82. PubMed ID: 16385829 [TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of histomorphological parameters and DNA content and their therapeutic consequences in esophageal carcinoma: a multivariate approach. Boettger T; Dutkowski P; Kirkpatrick CJ; Seifert JK; Junginger T Hepatogastroenterology; 1998; 45(22):994-1004. PubMed ID: 9755996 [TBL] [Abstract][Full Text] [Related]
8. Developing an appropriate staging system for esophageal carcinoma. Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691 [TBL] [Abstract][Full Text] [Related]
9. [Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy]. Chen EC; Liu MZ; Hu YH; Li QQ; Liu H; Cai L; Liu H; Lin HX; Huang Y; Wang HY; Cui NJ Ai Zheng; 2005 Jun; 24(6):731-4. PubMed ID: 15946490 [TBL] [Abstract][Full Text] [Related]
10. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Rohatgi PR; Swisher SG; Correa AM; Wu TT; Liao Z; Komaki R; Walsh G; Vaporciyan A; Lynch PM; Rice DC; Roth JA; Ajani JA Cancer; 2005 Oct; 104(7):1349-55. PubMed ID: 16130133 [TBL] [Abstract][Full Text] [Related]
11. Long-term effects of hyperthermia combined with chemotherapy and irradiation for the treatment of patients with carcinoma of the esophagus. Sugimachi K; Matsuda H; Ohno S; Fukuda A; Matsuoka H; Mori M; Kuwano H Surg Gynecol Obstet; 1988 Oct; 167(4):319-23. PubMed ID: 3420507 [TBL] [Abstract][Full Text] [Related]
12. [Cox regression analysis of the prognostic factors of unresectable esophageal carcinoma after stenting]. Fu JH; Rong TH; Li XD; Ma GW; Hu Y; Min HQ Ai Zheng; 2003 Jan; 22(1):91-4. PubMed ID: 12561445 [TBL] [Abstract][Full Text] [Related]
13. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction. Zhang X; Watson DI; Jamieson GG Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216 [TBL] [Abstract][Full Text] [Related]
14. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. Rizk N; Venkatraman E; Park B; Flores R; Bains MS; Rusch V; J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1374-81. PubMed ID: 17140960 [TBL] [Abstract][Full Text] [Related]
15. Esophageal prosthesis in palliation of malignant esophageal obstruction. Govil A; Kumar N Trop Gastroenterol; 1995; 16(1):49-58. PubMed ID: 7544040 [TBL] [Abstract][Full Text] [Related]
16. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Das A; Singh V; Fleischer DE; Sharma VK Am J Gastroenterol; 2008 Jun; 103(6):1340-5. PubMed ID: 18510606 [TBL] [Abstract][Full Text] [Related]
17. Individualized surgical strategies for cancer of the esophagogastric junction. Stein HJ; Feith M; Siewert JR Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787 [TBL] [Abstract][Full Text] [Related]
18. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy followed by surgery in patients with carcinoma of the distal esophagus and celiac lymph node involvement. Boonstra JJ; Koppert LB; Wijnhoven BP; Tilanus HW; Van Dekken H; Tran TC; Van der Gaast A J Surg Oncol; 2009 Oct; 100(5):407-13. PubMed ID: 19653239 [TBL] [Abstract][Full Text] [Related]